COVID-19 RT-PCR Testing Solutions
Virant Diagnostics provides customized COVID-19 testing, including on-site test collection and optional same-day test result using FDA EUA RT-PCR diagnostic assay.
COVID-19 RT-PCR Testing Solutions
Virant Diagnostics: A High Complexity CLIA Lab Specializing in COVID-19 Molecular RT-PCR Assays
- Qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens
- Same-day RT-PCR test results
- RT-PCR assay greater than 99% sensitivity and specificity
- The “Gold-Standard” for coronavirus detection – Nuclei Acid Amplification Test (NAAT)
- Ability to detect all current SARS-CoV-2 Mutational Variants
We Can Help Your Organization
Achieve Fast Test Results: We can provide same day test results
Data Integration: We can interface with most healthcare EMR for test ordering and test result lookup
Flexible Solutions: Customized to meet your organization’s needs
Competitive Costs: Virant Diagnostics will offers competitive business-to-business, or insurance billing for COVID-19 RT-PCR
COVID-19 RT-PCR Testing Solutions
Virant Diagnostics uses the Highest Quality of Molecular Assay for Detecting SARS-Cov-2 Virus
- Applied Biosystems™ (Thermo Fisher Scientific) FDA EUA TaqPath™ COVID-19 Combo Test
- High complexity and high throughput testing with the Applied Biosystems Instruments
- Highly sensitive multiplex diagnostic solution for real-time PCR detection of SARS-CoV-2 viral RNA
- The TaqPath assay targets spike (S), open-reading frame (ORF) and nucleocapsid (N) protein regions, thus enabling higher specificity and exhibiting lower risk for mutation evasion